COVID-19 Research Community Forum- Week 4: Building a Research Infrastructure for Equity in COVID-19 Treatment
Presented by Dr. Benjamin Linas, MD, MPH, Associate Professor of Medicine, Infectious Diseases, BUSM and hosted by Dr. Tracy Battaglia, MD, MPH, BU CTSI Community Engagement Program Director.
To see the previous COVID-19 Research Community Forums sponsored by the four CTSA’s of Massachusetts click the button below.
Boston Musculoskeletal Clinical Research Collaboratory, a NIAMS funded CCCR will award one grant per year for a project period of 12 months. (Funding available: $22,500)
Pfizer Invites Applications for Gene & Anti-TFPI Therapies in Hemophilia Grant Program
Pfizer has issued an RPF for its Gene & Anti-TFPI Therapies in Hemophilia competitive grant program. (Funding available: $125,000 a year for up to two years
NANETS/NETRF Basic/Translational Science Investigator Award
NETRF offers four different neuroendocrine cancer research grants ( Accelerator,Investigator,Pilot, andMentored Awards) with cancer research grants ranging from $100,000 to $1.2 million.
NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19)
The Prime Cellular Targets for the Novel Coronavirus
There’s still a lot to learn about SARS-CoV-2, the novel coronavirus that causes COVID-19. But it has been remarkable and gratifying to watch researchers from around the world pull together and share their time, expertise, and hard-earned data in the urgent quest to control this devastating virus.
AMIA’s Virtual Clinical Informatics Conference (CIC) is where practitioners in health informatics, including physicians, nurses, physician assistants, technicians, HIT developers, data analysts, C-suite executives, and all members of the health care team, come together at their home conference.
